The PI3K/AKT signaling pathway is considered to be one of the most crucial pathways involved in cancer initiation and progression 23, and several studies have underlined a potential role of PI3K/AKT activation in promoting drug resistance of HCC 29, 54. The gene discussed is AKT1; the disease is hepatocellular carcinoma.